Table 1.

Examples of new low- and high-molecular-weight boron delivery agents currently under evaluation*

Boronated unnatural amino acids [12-14]	Carboranyl nucleosides [16,17]
Dodecaborate cluster lipids and cholesterol derivatives [18]	Boronated porphyrins [19-21]
Boron containing immunoliposomes [22] and liposomes [23-26]	Boronated EGF and anti-EGFR and VEGFR MoAbs [27-33]
Boronated DNA intercalators [34]	Boron-containing nanoparticles [35,36]
Transferrin–polyethylene glycol (TF–PEG) liposomes [37,38]	Carboranyl porphyrazines [39]
Dodecahyrdo-closo-dodecaborate clusters [18]	Boronated cyclic peptides [15]
	Boron nitride nanotubes [40]

* The numbers indicated in brackets are cited in the reference section.